Literature DB >> 17993727

Predicting resectability of pancreatic head cancer with multi-detector CT. Surgical and pathologic correlation.

Damien Olivié1, Luigi Lepanto, Jean Sébastien Billiard, Pascale Audet, Jessica Murphy Lavallée.   

Abstract

CONTEXT: Computed tomography is widely used to pre-operatively evaluate patients with ductal carcinoma of the pancreas.
OBJECTIVE: To prospectively evaluate the ability of multi-detector computed tomography to predict resectability of pancreatic head cancer. PATIENTS: Ninety-one consecutive patients (53 men, 38 women; mean age, 61 years) referred to our department with a diagnosis of cancer of the head of the pancreas underwent a preoperative contrast enhanced triphasic 16-slice multi-detector computed tomography. Sixty-three were considered inoperable because of advanced local disease, metastatic disease, or poor surgical risk. INTERVENTION: Of the remaining 28 patients, 23 underwent a Whipple procedure, whereas 5 patients underwent a palliative procedure. MAIN OUTCOME MEASURES: Surgical and pathologic reports were reviewed and compared to CT results.
RESULTS: Of the 91 patients evaluated, 25% had successful resection of pancreatic head carcinoma; while only 5% had a palliative procedure. When compared to surgical outcome, the positive predictive value of multi-detector computed tomography for resectability was 100%. On the basis of pathologic results, the positive predictive value of multi-detector computed tomography for resectability fell to 83%, Four patients deemed resectable following multi-detector computed tomography had positive margins at pathology.
CONCLUSION: The positive predictive value of multi-detector computed tomography for resectable disease is lower when pathologic correlation, as opposed to surgical correlation, is used as the gold standard. Compared to previous studies, there was a lower rate of palliative surgery in our cohort.

Entities:  

Mesh:

Year:  2007        PMID: 17993727

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  9 in total

1.  Predictors of conversion surgery in patients with pancreatic cancer who underwent neoadjuvant or palliative FOLFIRINOX treatment using baseline and follow-up CT.

Authors:  Sae-Jin Park; Jung Hoon Kim; Ijin Joo; Joon Koo Han
Journal:  Abdom Radiol (NY)       Date:  2021-06-03

2.  MDCT findings predicting post-operative residual tumor and survival in patients with pancreatic cancer.

Authors:  Jae Seok Bae; Jung Hoon Kim; Ijin Joo; Won Chang; Joon Koo Han
Journal:  Eur Radiol       Date:  2019-03-21       Impact factor: 5.315

Review 3.  Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.

Authors:  Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

4.  Role of Multi Detector Computed Tomography (MDCT) in Preoperative Staging of Pancreatic Carcinoma.

Authors:  Soumil Singhal; Nirmal Kumar Prabhu; Pulkit Sethi; Srikanth Moorthy
Journal:  J Clin Diagn Res       Date:  2017-05-01

5.  Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen W Behrman; Edgar Ben-Josef; Al B Benson; Ephraim S Casper; Steven J Cohen; Brian Czito; Joshua D I Ellenhorn; William G Hawkins; Joseph Herman; John P Hoffman; Andrew Ko; Srinadh Komanduri; Albert Koong; Wen Wee Ma; Mokenge P Malafa; Nipun B Merchant; Sean J Mulvihill; Peter Muscarella; Eric K Nakakura; Jorge Obando; Martha B Pitman; Aaron R Sasson; Anitra Tally; Sarah P Thayer; Samuel Whiting; Robert A Wolff; Brian M Wolpin; Deborah A Freedman-Cass; Dorothy A Shead
Journal:  J Natl Compr Canc Netw       Date:  2012-06-01       Impact factor: 11.908

6.  Very high serum CA 19-9 levels: a contraindication to pancreaticoduodenectomy?

Authors:  O Turrini; C M Schmidt; J Moreno; P Parikh; J M Matos; M G House; N J Zyromski; A Nakeeb; H A Pitt; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2009-05-21       Impact factor: 3.452

Review 7.  Multimodality imaging of pancreatic ductal adenocarcinoma: a review of the literature.

Authors:  Shailesh V Shrikhande; Savio George Barreto; Mahesh Goel; Supreeta Arya
Journal:  HPB (Oxford)       Date:  2012-06-14       Impact factor: 3.647

8.  Contrast-enhanced CT in determining resectability in patients with pancreatic carcinoma: a meta-analysis of the positive predictive values of CT.

Authors:  Inne Somers; Shandra Bipat
Journal:  Eur Radiol       Date:  2017-01-16       Impact factor: 5.315

9.  Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapy.

Authors:  Zhi Cheng; Lauren M Rosati; Linda Chen; Omar Y Mian; Yilin Cao; Marta Villafania; Minoru Nakatsugawa; Joseph A Moore; Scott P Robertson; Juan Jackson; Amy Hacker-Prietz; Jin He; Christopher L Wolfgang; Matthew J Weiss; Joseph M Herman; Amol K Narang; Todd R McNutt
Journal:  Adv Radiat Oncol       Date:  2018-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.